Dr. Oshima is a hepatobiliary and gastrointestinal pathologist and the director of the Johns Hopkins Liver Pathology Service.
Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.
Languages: English, Japanese
Her research focuses on the study of neoplastic and non-neoplastic processes of the liver and pancreatobiliary tract. Her ongoing projects include: 1) ) 2D and 3D morphologic analysis of cholangiocarcinoma 2) digital image morphologic analysis of treatment effect on pancreatic adenocarcinoma post neoadjuvant therapy 3) morphologic analysis of hepatic hemangioendothelioma 4) early diagnosis of nodular regenerative hyperplasia with immunohistochemical stains.
Rowan DJ, Logunova V, Oshima K. Measured residual tumor cellularity correlates with survival in neoadjuvant treated pancreatic ductal adenocarcinomas. Ann Diagn Pathol. 2019 Feb; 38:93-98.
Eskandari F, Rowan DJ, Hari P, Kapke J, Schneidewend R, E Hagen C, Oshima K. Liver biopsy findings in patients with hematopoietic cell transplantation. Hum Pathol. 2017 Aug; 66:136-143.
Pant M, Oshima K. Cholesteryl Ester Storage Disease: An underdiagnosed cause of cirrhosis in adults. Ann Diagn Pathol. 2017 Dec; 31:66-70.
Zen Y, Adsay N, Bardadin K, Colombari R, Farrell L, Haga H, Hong S, Hytiroglou P, Kloppel G, Lauwers G, Leeuwen D, Notohara K, Oshima K, Quaglia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y. Biliary intraepithelial neoplasia: An international interobserver agreement study and proposal of the revised diagnostic criteria. Mod Pathol 2007 Jun; 20(6):701-9.
Educational Travel and Awards Committee